Home Newsletters Immune Regulation News Niraparib Exhibits a Synergistic Anti-Tumor Effect with PD-L1 Blockade by Inducing an...

Niraparib Exhibits a Synergistic Anti-Tumor Effect with PD-L1 Blockade by Inducing an Immune Response in Ovarian Cancer

0
Programmed death ligand 1 (PD-L1) expression in human ovarian cancer cells after PARP inhibitors treatment was examined by western blotting and flow cytometry.
[Journal of Translational Medicine]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version